Nasal Packaging Devices Market Size, Share, Opportunities, And Trends By Product (Injectable, Gel, Spray, Dressings), By Type (Bio-Resorbable, Non-Absorbable), By End-User (Hospitals, Clinics, Others), And By Geography - Forecasts From 2023 To 2028

  • Published : Aug 2023
  • Report Code : KSI061616031
  • Pages : 142

The nasal packaging market is anticipated to grow at a steady pace throughout the forecast period. Nasal packaging devices are medical devices designed to provide support, control bleeding, and prevent adhesions (tissue sticking together) in the nasal cavity after various procedures. These devices are often used following nasal surgeries, such as septoplasty, rhinoplasty, or sinus surgery, where the nasal tissues can be delicate and prone to bleeding. The rising prevalence of nasal problems coupled with increasing awareness and more surgeries are major growth drivers of the nasal packaging devices market. Moreover, the rapidly growing elderly population along with the technological developments in packaging is further contemplated to accelerate the market expansion.

Rising Incidence of Nasal Conditions

As the prevalence of nasal conditions such as chronic sinusitis, deviated septum, and nasal trauma continues to rise, the demand for nasal packaging devices to manage these conditions post-surgery or as part of treatment plans increases. For instance, sinusitis affects around 30 million persons in the United States alone each year. It has an economic effect of billions of dollars and millions of days of missed work time according to the Sinus & Allergy Wellness Centre. Moreover, sinusitis accounts for roughly 73 million restricted activity days each year. Around 70 to 80 percent of individuals exhibit a noticeable deviation of the nasal septum according to a Mayo Clinic.

Growing Number of Surgical Procedures

The number of nasal surgeries, including rhinoplasty, septoplasty, and sinus surgeries, is on the rise globally. These procedures often require nasal packaging devices to control bleeding, promote healing, and ensure optimal surgical outcomes. For instance, the otolaryngology Department of the University of Michigan Health performs nearly 500 nasal surgical interventions and around 16 million patients visit in a year. Additionally, around 700 functional endoscopic sinus surgery procedures are done at UT Southwestern each year as per the statement of M.D. Professor of Otolaryngology.

Advancements in Packaging Technology

Technological innovations have led to the development of more effective and patient-friendly nasal packaging devices. These advancements include the use of biocompatible materials, improved designs, and less invasive insertion techniques. The use of biocompatible materials, such as medical-grade silicone, hydrogels, and absorbable polymers, in nasal packaging devices minimizes tissue irritation, reduces the risk of allergic reactions, and promotes better healing. Advancements in 3D printing technology allow for the creation of personalized nasal packaging devices tailored to individual patients' nasal anatomy. This promotes a better fit and improved post-operative outcomes. Additionally, some nasal packaging devices incorporate drug-eluting capabilities, releasing medications or therapeutic agents directly into the nasal cavity to enhance healing, reduce inflammation, and prevent infection.

Aging Population

The aging population is more prone to nasal and sinus-related issues. As the global population continues to age, the demand for nasal surgeries and associated devices is likely to increase thereby stimulating the nasal packaging devices market. Individuals experiencing geriatric rhinitis might encounter symptoms such as blocked or congested nasal passages, excessive nasal discharge, itching in the nose, sneezing, as well as dryness or the formation of crusts within the nasal passages. For instance, the percentage of people aged over 60 years worldwide will increase from 12% to 22% between 2015 and 2050 according to the WHO.

Increasing Awareness and Education

As awareness among patients and healthcare professionals about the benefits of proper post-operative care increases, the nasal packaging devices market is likely to grow. Several initiatives are being undertaken in this aim. For instance, in March 2021, a Henry Ford physician launched a worldwide study effort to increase interdisciplinary collaboration between otolaryngologists and dental professionals throughout the world for detecting odontogenic sinusitis (ODS). Moreover, Annually, the American Academy of Otolaryngology–Head and Neck Surgery (AAO-HNS) endorses the recognition of World Sinus Health Awareness Day. In 2022, this sponsorship was carried out in partnership with the American Rhinologic Society and in collaboration with the corporate partner Medtronic.

Restraints in the Market

The nasal packaging devices market has experienced growth and development however some restraints or challenges can impact its expansion. For example, developing and manufacturing advanced nasal packaging devices with cutting-edge materials and technologies can lead to higher production costs. These costs can subsequently impact pricing and accessibility for patients and healthcare providers. The use of disposable nasal packaging devices can contribute to medical waste. As sustainability becomes a more significant concern, there may be pressure to develop environmentally friendly packaging solutions.

North America is Expected to Grow Considerably

North America is expected to hold a significant share of the nasal packaging devices market during the forecast period. The factors attributed to such a share are the growing use of nasal packing devices to treat a rising number of epistaxis patients due to the rising nose and sinus disorders, as well as an increase in the number of market players in the region. For instance, chronic sinusitis affects nearly 31 million people in the US according to the University of Michigan Health.

Major Market Players

  • Anthony Products is a company that specializes in manufacturing and supplying medical devices, instruments, and equipment for a wider range of medical fields including otolaryngology. It deals in nasal drip pads, 30-second rhino rocket nasal packs, and more.
  • Innovia Medical, founded in 1978 is a surgical specialty company in various fields such as aesthetics, ear, nose, and throat, among others.  AbsorbENT® Anatomical Nasal Packs are offered by the company for epistaxis management. It uses three-dimensional linked open cells that are soft and malleable.
  • Nipro, established in 1954 is a Japanese medical equipment manufacturing company. The Exadose™ Nasal Spray offered by the company has a novel two-step quantitative delivery method. The unique plunger design guarantees that half a dosage is administered precisely in each nasal cavity.

Key Market Developments

  • In July 2023, FDA approved RiVive™ Over-the-Counter Nasal Spray developed by Harm Reduction Therapeutics for the emergency treatment of opioid overdose.
  • In December 2020, Medtronic launched the Novapak Nasal Sinus Packing and Stent, a disposable and dissolvable packing specifically designed for post-sinus surgery use. It helps control bleeding, prevent adhesions, and create a moist healing environment for rapid patient recovery.


  • By Product
    • Injectable
    • Gel
    • Spray
    • Dressings
  • By Type
    • Bio-Resorbable
    • Non-Absorbable
  • By End-User
    • Hospitals
    • Clinics
    • Others
  • By Geography
    • North America
      • United States
      • Canada
      • Mexico
    • South America
      • Brazil
      • Argentina
      • Others
    • Europe
      • United Kingdom
      • Germany
      • France
      • Spain
      • Others
    • Middle East and Africa
      • Saudi Arabia
      • UAE
      • Israel
      • Others
    • Asia Pacific
      • Japan
      • China
      • India
      • South Korea
      • Indonesia
      • Thailand
      • Others


1.1. Market Overview

1.2. Market Definition

1.3. Scope of the Study

1.4. Market Segmentation

1.5. Currency

1.6. Assumptions

1.7. Base, and Forecast Years Timeline


2.1. Research Data

2.2. Assumptions


3.1. Research Highlights


4.1. Market Drivers

4.2. Market Restraints

4.3. Porter’s Five Force Analysis

4.3.1. Bargaining Power of Suppliers

4.3.2. Bargaining Power of Buyers

4.3.3. Threat of New Entrants

4.3.4. Threat of Substitutes

4.3.5. Competitive Rivalry in the Industry

4.4. Industry Value Chain Analysis


5.1. Introduction

5.2. Injectable

5.3. Gel

5.4. Spray

5.5. Dressings


6.1. Introduction

6.2. Bio-Resorbable

6.3. Non-Absorbable


7.1. Introduction

7.2. Hospitals

7.3. Clinics

7.4. Others


8.1. Introduction

8.2. North America

8.2.1. United States

8.2.2. Canada

8.2.3. Mexico

8.3. South America

8.3.1. Brazil

8.3.2. Argentina

8.3.3. Others

8.4. Europe

8.4.1. United Kingdom

8.4.2. Germany

8.4.3. France

8.4.4. Spain

8.4.5. Others

8.5. The Middle East and Africa

8.5.1. Saudi Arabia

8.5.2. UAE

8.5.3. Israel

8.5.4. Others

8.6. Asia Pacific

8.6.1. Japan

8.6.2. China

8.6.3. India

8.6.4. South Korea

8.6.5. Indonesia

8.6.6. Thailand

8.6.7. Others


9.1. Major Players and Strategy Analysis

9.2. Market Share Analysis

9.3. Mergers, Acquisitions, Agreements, and Collaborations

9.4. Vendor Competitiveness Matrix


10.1. Meril Life

10.2. Anthony Products

10.3. Medtronic

10.4. Entsho

10.5. Innovia Medical

10.6. Cenefom

10.7. Nipro

10.8. Lohmann & Rauscher

10.9. Medline

Meril Life

Anthony Products



Innovia Medical



Lohmann & Rauscher